FONAR Corp. (FONR) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1154363,
    "name": "FONAR Corp.",
    "stock_name": "FONAR Corp.",
    "full_name": "FONAR Corp.",
    "name_url": "stocks-analysis/fonar-corp",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "14.64",
    "chg": 0.25,
    "chgp": "1.77%",
    "dir": 1,
    "prev_price": "14.39",
    "mcapval": "98.62",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Miscellaneous",
    "ind_code": 3205,
    "indexname": "S&P 500",
    "isin": "US3444374058",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "84.26 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/fonar-corp-1154363-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is FONAR Corp. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-fonar-corp-overvalued-or-undervalued-3637314",
        "imagepath": "",
        "date": "2025-10-21 11:59:47",
        "description": "As of 17 October 2025, the valuation grade for FONAR Corp. has moved from attractive to fair, indicating a shift in its perceived value. Based on the current metrics, the company appears to be fairly valued. Key ratios include a P/E ratio of 8, a Price to Book Value of 0.53, and an EV to EBITDA of 2.31, which suggest that the stock is trading at a discount relative to its earnings and book value.\n\nIn comparison to peers, FONAR Corp. has a P/E ratio of 8.9956, while Longboard Pharmaceuticals, Inc. shows a significantly negative P/E of -27.0419, indicating that FONAR is in a better position relative to this peer. The return performance of FONAR Corp. has lagged behind the S&P 500, with a 1Y return of -1.08% compared to the S&P 500's 14.08%, reflecting challenges in the stock's performance over the past year...."
      },
      {
        "title": "FONAR Corp. Experiences Valuation Adjustment Amidst Challenging Market Conditions",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fonar-corp-valuation-grade-downgraded-from-attractive-to-fair-amid-price-decline-3640663",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/FONARCorp_valuationdot_3640663.png",
        "date": "2025-10-20 16:03:30",
        "description": "FONAR Corp. has recently adjusted its valuation, with its stock price at $15.50. Over the past year, the company has seen a stock return of -1.08%, compared to the S&P 500's 14.08%. Key metrics include a P/E ratio of 8 and a return on equity of 6.38%."
      },
      {
        "title": "Is FONAR Corp. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-fonar-corp-overvalued-or-undervalued-3631723",
        "imagepath": "",
        "date": "2025-10-19 11:55:27",
        "description": "As of 17 October 2025, the valuation grade for FONAR Corp. has moved from attractive to fair, indicating a shift in its perceived value. Based on the current metrics, the company appears to be fairly valued. Key valuation ratios include a P/E ratio of 8, a Price to Book Value of 0.53, and an EV to EBITDA of 2.31, which suggest that the stock is trading at a discount relative to its earnings and book value.\n\nIn comparison to peers, FONAR Corp. has a P/E ratio of 8.9956, which is relatively better than the risky peers like Longboard Pharmaceuticals, Inc. with a P/E of -27.0419 and Performant Financial Corp. with a P/E of -602.7473. While FONAR Corp.'s performance has lagged behind the S&P 500 in the longer term, with a 5-year return of -27.06% compared to the S&P 500's 91.29%, it has shown some resilience in the short term with a year-to-date return of 2.38%...."
      },
      {
        "title": "Is FONAR Corp. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-fonar-corp-technically-bullish-or-bearish-3544868",
        "imagepath": "",
        "date": "2025-09-20 18:58:02",
        "description": "As of 24 July 2025, the technical trend for FONAR Corp. has changed from mildly bearish to mildly bullish. The weekly MACD is bullish, supporting the positive trend, while the daily moving averages also indicate a mildly bullish stance. However, the monthly Bollinger Bands are bearish, and the KST shows a mixed signal with a bullish weekly but bearish monthly reading. The overall technical stance is mildly bullish, driven primarily by the weekly MACD and moving averages. \n\nIn terms of multi-period returns, FONAR has underperformed the S&P 500 year-to-date and over the past year, with returns of 2.44% and -10.86%, respectively, compared to the S&P 500's 12.22% and 17.14%. Over three years, FONAR shows a return of 8.84%, significantly lagging behind the S&P 500's 70.41%...."
      },
      {
        "title": "Is FONAR Corp. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-fonar-corp-overvalued-or-undervalued-3541594",
        "imagepath": "",
        "date": "2025-09-20 17:29:59",
        "description": "As of 21 July 2025, the valuation grade for FONAR Corp. has moved from attractive to fair, indicating a shift in its perceived value. The company appears to be fairly valued at this time. Key valuation ratios include a P/E ratio of 8, a Price to Book Value of 0.53, and an EV to EBITDA of 2.31. \n\nIn comparison to its peers, FONAR Corp. has a P/E ratio of 8.9956, which is relatively favorable given that Longboard Pharmaceuticals, Inc. has a significantly negative P/E of -27.0419, while Performant Financial Corp. shows a risky valuation with a P/E of -602.7473. Despite its fair valuation, FONAR Corp. has underperformed against the S&P 500 over the past year, with a return of -10.86% compared to the index's 17.14%, suggesting that the market may be pricing in concerns regarding its future growth potential...."
      }
    ],
    "total": 10,
    "sid": "1154363",
    "stock_news_url": "https://www.marketsmojo.com/news/fonar-corp-1154363"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is FONAR Corp. overvalued or undervalued?

2025-10-21 11:59:47

As of 17 October 2025, the valuation grade for FONAR Corp. has moved from attractive to fair, indicating a shift in its perceived value. Based on the current metrics, the company appears to be fairly valued. Key ratios include a P/E ratio of 8, a Price to Book Value of 0.53, and an EV to EBITDA of 2.31, which suggest that the stock is trading at a discount relative to its earnings and book value. In comparison to peers, FONAR Corp. has a P/E ratio of 8.9956, while Longboard Pharmaceuticals, Inc. shows a significantly negative P/E of -27.0419, indicating that FONAR is in a better position relative to this peer. The return performance of FONAR Corp. has lagged behind the S&P 500, with a 1Y return of -1.08% compared to the S&P 500's 14.08%, reflecting challenges in the stock's performance over the past year....

FONAR Corp. Experiences Valuation Adjustment Amidst Challenging Market Conditions

2025-10-20 16:03:30

FONAR Corp. has recently adjusted its valuation, with its stock price at $15.50. Over the past year, the company has seen a stock return of -1.08%, compared to the S&P 500's 14.08%. Key metrics include a P/E ratio of 8 and a return on equity of 6.38%.

Is FONAR Corp. overvalued or undervalued?

2025-10-19 11:55:27

As of 17 October 2025, the valuation grade for FONAR Corp. has moved from attractive to fair, indicating a shift in its perceived value. Based on the current metrics, the company appears to be fairly valued. Key valuation ratios include a P/E ratio of 8, a Price to Book Value of 0.53, and an EV to EBITDA of 2.31, which suggest that the stock is trading at a discount relative to its earnings and book value. In comparison to peers, FONAR Corp. has a P/E ratio of 8.9956, which is relatively better than the risky peers like Longboard Pharmaceuticals, Inc. with a P/E of -27.0419 and Performant Financial Corp. with a P/E of -602.7473. While FONAR Corp.'s performance has lagged behind the S&P 500 in the longer term, with a 5-year return of -27.06% compared to the S&P 500's 91.29%, it has shown some resilience in the short term with a year-to-date return of 2.38%....

Is FONAR Corp. technically bullish or bearish?

2025-09-20 18:58:02

As of 24 July 2025, the technical trend for FONAR Corp. has changed from mildly bearish to mildly bullish. The weekly MACD is bullish, supporting the positive trend, while the daily moving averages also indicate a mildly bullish stance. However, the monthly Bollinger Bands are bearish, and the KST shows a mixed signal with a bullish weekly but bearish monthly reading. The overall technical stance is mildly bullish, driven primarily by the weekly MACD and moving averages. In terms of multi-period returns, FONAR has underperformed the S&P 500 year-to-date and over the past year, with returns of 2.44% and -10.86%, respectively, compared to the S&P 500's 12.22% and 17.14%. Over three years, FONAR shows a return of 8.84%, significantly lagging behind the S&P 500's 70.41%....

Is FONAR Corp. overvalued or undervalued?

2025-09-20 17:29:59

As of 21 July 2025, the valuation grade for FONAR Corp. has moved from attractive to fair, indicating a shift in its perceived value. The company appears to be fairly valued at this time. Key valuation ratios include a P/E ratio of 8, a Price to Book Value of 0.53, and an EV to EBITDA of 2.31. In comparison to its peers, FONAR Corp. has a P/E ratio of 8.9956, which is relatively favorable given that Longboard Pharmaceuticals, Inc. has a significantly negative P/E of -27.0419, while Performant Financial Corp. shows a risky valuation with a P/E of -602.7473. Despite its fair valuation, FONAR Corp. has underperformed against the S&P 500 over the past year, with a return of -10.86% compared to the index's 17.14%, suggesting that the market may be pricing in concerns regarding its future growth potential....

View All News